| __timestamp | Corcept Therapeutics Incorporated | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 14097000000 |
| Thursday, January 1, 2015 | 36949000 | 14809000000 |
| Friday, January 1, 2016 | 45240000 | 14837000000 |
| Sunday, January 1, 2017 | 62416000 | 14784000000 |
| Monday, January 1, 2018 | 81289000 | 14455000000 |
| Tuesday, January 1, 2019 | 100359000 | 14350000000 |
| Wednesday, January 1, 2020 | 105326000 | 11615000000 |
| Friday, January 1, 2021 | 122356000 | 12703000000 |
| Saturday, January 1, 2022 | 152848000 | 13677000000 |
| Sunday, January 1, 2023 | 184259000 | 14771000000 |
| Monday, January 1, 2024 | 14730000000 |
Data in motion
In the ever-evolving pharmaceutical industry, operational efficiency is key. Over the past decade, Pfizer Inc. and Corcept Therapeutics Incorporated have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. While Pfizer, a global giant, consistently reported SG&A expenses around $14 billion annually, Corcept, a smaller player, saw a significant rise from $35 million in 2014 to $184 million in 2023. This represents a staggering 426% increase for Corcept, highlighting its aggressive expansion strategy. In contrast, Pfizer's expenses remained relatively stable, reflecting its established market position. This analysis provides a fascinating glimpse into how different scales of operation impact financial strategies in the pharmaceutical sector. As the industry continues to grow, understanding these dynamics becomes crucial for investors and stakeholders alike.
Pfizer Inc. and Viatris Inc.: SG&A Spending Patterns Compared
Pfizer Inc. and Sarepta Therapeutics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Comparing SG&A Expenses: Pfizer Inc. vs Cytokinetics, Incorporated Trends and Insights
Pfizer Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
argenx SE or Corcept Therapeutics Incorporated: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Incyte Corporation and Corcept Therapeutics Incorporated
Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Corcept Therapeutics Incorporated and Perrigo Company plc: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
Corcept Therapeutics Incorporated and Geron Corporation: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.